Studies on antimalarial drug susceptibility in Colombia, in relation to Pfmdr1 and Pfcrt

Parasitology

Volumn 135, Issue 5, 2008, Pages 547-553

  Restrepo Pineda, E ^a   Arango, E ^a   Maestre, A ^a   Rosário, V E Do ^b   Cravo, P ^b  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

Author keywords

Colombia; Malaria; Pfcrt; Pfmdr; Plasmodium falciparum

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTESUNATE; CHLOROQUINE; DEETHYLAMODIAQUINE; DIHYDROARTESUNATE; MEFLOQUINE; QUININE; UNCLASSIFIED DRUG; CARRIER PROTEIN; DRUG DERIVATIVE; MDR1 PROTEIN, PLASMODIUM FALCIPARUM; MULTIDRUG RESISTANCE PROTEIN; PFCRT PROTEIN, PLASMODIUM FALCIPARUM; PROTOZOAL PROTEIN;

ALLELE; ARTICLE; CODON; COLOMBIA; CORRELATION ANALYSIS; DRUG SENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; GENE MUTATION; HAPLOTYPE; HUMAN; IC 50; IN VITRO STUDY; MAJOR CLINICAL STUDY; NONHUMAN; PFCRT GENE; PFMDR1 GENE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTOZOAL GENETICS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; DRUG EFFECT; DRUG RESISTANCE; GENETICS; MALARIA FALCIPARUM; PARASITOLOGY;

ARTESUNATE; PLASMODIUM FALCIPARUM;

AMODIAQUINE; ANIMALS; ANTIMALARIALS; CHLOROQUINE; COLOMBIA; DRUG RESISTANCE; HUMANS; MALARIA, FALCIPARUM; MEFLOQUINE; MEMBRANE TRANSPORT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTOZOAN PROTEINS;

EID: 42449088889     PISSN: 00311820     EISSN: 14698161     Source Type: Journal    
DOI: 10.1017/S0031182008004307     Document Type: Article

References (40)

1. Afonso, A., Hunt, P., Cheesman, S. A., Alves, C., Cunha, C. V., Rosário, V. and Cravo, P. (2006). Malaria parasites can develop stable resistance to artemisinin but lack mutations in candidate genes atp6 (encoding the sarcoplasmic and endoplasmic reticulum Ca2+ ATPase), tctp, mdr1, and cg10. Antimicrobial Agents and Chemotherapy 50, 480-489.
2. Babiker, H. A., Pringle, S. J., Abdel-Muhsin, A., Mackinnon, M., Hunt, P. and Walliker, D. (2001). High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance gene pfmdr1. Journal of Infectious Diseases 183, 1535-1538.
3. Basco, L. K. and Ringwald, P. (2002). Molecular epidemiology of malaria in Cameroon. X. Evaluation of PFMDR1 mutations as genetic markers for resistance to amino alcohols and artemisinin derivatives. American Journal of Tropical Medicine and Hygiene 66, 667-671.
4. Bjorkman, A. and Bhattarai, A. (2005). Public health impact of drug resistant Plasmodium falciparum malaria. Acta Tropica 94, 163-169.
5. Blair, S., Carmona-Fonseca, J., Piñeros, J. G., Ríos, A., Alvarez, T., Alvarez, G. and Tobón, A. (2006). Therapeutic efficacy test in malaria falciparum in Antioquia, Colombia. Malaria Journal 5, 14.
6. Blair, S., Lopez, M. L., Piñeros, J. G., Alvarez, T., Tobon, A. and Carmona, J. (2003). Therapeutic efficacy of 3 treatment protocols for non-complicated Plasmodium falciparum malaria, Antioquia, Colombia, 2002. Biomedica 23, 318-327.
7. Cortese, J. F., Caraballo, A., Contreras, C. E. and Plowe, C. (2002). Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America. Journal of Infectious Diseases 186, 999-1006.
8. Djimde, A., Doumbo, O. K., Cortese, J. F., Kayentao, K., Doumbo, S., Diourte, Y., Dicko, A., Su, X. Z., Nomura, T., Fidock, D. A., Wellems, T. E., Plowe, C. V. and Coulibaly, D. (2001a). A molecular marker for chloroquine-resistant falciparum malaria. New England Journal of Medicine 344, 257-263.
9. Djimde, A., Doumbo, O. K., Steketee, R. W. and Plowe, C. V. (2001b). Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria. Lancet 358, 890-891.
10. Duraisingh, M. T., Jones, P., Sambou, I., Von Seidlein, L., Pinder, M. and Warhurst, D. C. (2000). The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Molecular and Biochemical Parasitology 108, 13-23.
11. Duraisingh, M. and Refour, P. (2005). Multiple drug resistance genes in malaria - from epistasis to epidemiology. Molecular Microbiology, 57, 874-877.
12. Ferreira, I. D., Lopes, D., Martinelli, A., Ferreira, C., do Rosário, V. E. and Cravo, P. (2007). In vitro assessment of artesunate, artemether and amodiaquine susceptibility and molecular analysis of putative resistance-associated mutations of Plasmodium falciparum from Sao Tome and Principe. Tropical Medicine and International Health 12, 353-362.
13. Fidock, D. A., Nomura, T., Talley, A. K., Cooper, R. A., Dzekunov, S. M., Ferdig, M. T., Ursos, L. M. B., Singh Sidhu, A. B., Naude, B., Deitsch, K. W., Su, X. Z., Wootton, J. C., Roepe, P. D. and Wellems, T. E. (2000). Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Molecular Cell 6, 861-871.
14. Foote, S. J., Kyle, D. E., Martin, R. K., Oduola, A. M., Forsyth, K., Kemp, D. J. and Cowman, A. F. (1990). Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature, London 345, 255-258.
15. Howard, E. M., Zhang, H. and Roepe, P. D. (2002). A novel transporter, Pfcrt, confers antimalarial drug resistance. Journal of Membrane Biology 190, 1-8.
16. Lopes, D., Nogueira, F., Ferreira, C., Gil, J. P., do Rosário, V. E. and Cravo, P. (2002). pfcrt and pfmdr1 mutations and chloroquine resistance in Plasmodium falciparum from Sao Tome and Principe, West Africa. Annals of Tropical Medicine and Parasitology 96, 831-834.
17. Menard, D., Djalle, D., Manirakiza, A., Yapou, F., Siadoua, V., Sana, S., Matsika-Claquin, M. D., Nestor, M. and Talarmin, A. (2005). Drug-resistant malaria in Bangui, Central African Republic: an in vitro assessment. American Journal of Tropical Medicine and Hygiene 73, 239-243.
18. Mita, T., Kaneko, A., Lum, J. K., Bwijo, B., Takechi, M., Zungu, I. L., Tsukahara, T., Tanabe, K., Kobayakawa, T. and Bjorkman, A. (2003). Recovery of chloroquine sensitivity and low prevalence of the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuance of chloroquine use in Malawi. American Journal of Tropical Medicine and Hygiene 68, 413-415.
19. Montoya, P., Tobón, A., Blair, S., Carmona, J. and Maestre, A. (2007). Polimorfismos del gen pfmdr1 en muestras clínicas de Plasmodium falciparum y su relación con la respuesta terapéutica a antipalúdicos y paludismo grave en Colombia. Biomedica 27, 204-215.
20. Moore, D.V and Lanier, J. E. (1961). Observations on two Plasmodium falciparum infections with an abnormal response to chloroquine. American Journal of Tropical Medicine and Hygiene 10, 5-9.
21. Noedl, H., Attlmayr, B., Wernsdorfer, W. H., Kollaritsch, H. and Miller, R. S. (2004). A histidine-rich protein 2-based malaria drug sensitivity assay for field use. American Journal of Tropical Medicine and Hygiene 71, 711-714.
22. Noedl, H., Bronnert, J., Yingyuen, K., Attlmayr, B., Kollaritsch, H. and Fukuda, M. (2005). Simple histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing. Antimicrobial Agents and Chemotherapy 49, 3575-3577.
23. Noedl, H., Wernsdorfer, WH., Miller, R. S. and Wongsrichanalai, C. (2002). Histidine-rich protein II: a novel approach to malaria drug sensitivity testing. Antimicrobial Agents and Chemotherapy 46, 1658-1664.
24. Nsimba, B., Jafari-Guemouri, S., Malonga, D. A., Mouata, A. M., Kiori, J., Louya, F., Yocka, D., Malanda, M., Durand, R. and Le Bras, J. (2005). Epidemiology of drug-resistant malaria in Republic of Congo: using molecular evidence for monitoring antimalarial drug resistance combined with assessment of antimalarial drug use. Tropical Medicine and International Health 10, 1030-1037.
25. Plowe, C. V., Djimde, A., Bouare, M., Doumbo, O. and Wellems, T. E. (1995). Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. American Journal of Tropical Medicine and Hygiene 52, 565-568.
26. Pradines, B., Mabika Mamfoumbi, M., Parzy, D., Owono Medang, M., Lebeau, C., Mourou Mbina, J. R., Doury, J. C. and Kombila, M. (1998). In vitro susceptibility of Gabonese wild isolates of Plasmodium falciparum to artemether, and comparison with chloroquine, quinine, halofantrine and amodiaquine. Parasitology 117, 541-545.
27. Price, N. R., Uhlemann, A. C., Brockman, A., McGready, R., Ashley, E., Phaipun, L., Patel, R., Laing, K., Looareesuwan, S., White, N. J., Nosten, F. and Krishna, S. (2004). Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 364, 438-447.
28. Reed, M. B., Saliba, K. J., Caruana, S. R., Kirk, K. and Cowman, A. F. (2000). Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature, London 403, 906-909.
29. Rodriguez, D. C. (1961). Cases of malaria caused by Plasmodium falciparum resistant to treatment with chloroquine. Arquivos da Higiene e Saude Publica 26, 231-235.
30. Sanchez, C. P., McLean, J. E., Rohrbach, P., Fidock, D. A., Stein, W. D. and Lanzer, M. (2005). Evidence for a pfcrt-associated chloroquine efflux system in the human malarial parasite Plasmodium falciparum. Biochemistry 44, 9862-9870.
31. Sidhu, A. B., Uhlemann, A. B., Valderramos, S. G., Valderramos, J. C., Krishna, S. and Fidock, D. A. (2006). Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. Journal of Infectious Diseases 194, 528-535.
32. Tinto, H., Rwagacondo, C., Karema, C., Mupfasoni, D., Vandoren, W., Rusanganwa, E., Erhart, A., Van Overmeir, C., Van Marck, E. and D'Alessandro, U. (2006). In-vitro susceptibility of Plasmodium falciparum to monodesethylamodiaquine, dihydroartemisinin and quinine in an area of high chloroquine resistance in Rwanda. Transactions of the Royal Society of Tropical Medicine and Hygiene 100, 509-514.
33. Vinayak, S., Biswas, S., Dev, V., Kumar, A., Ansari, M. A. and Sharma, Y. D. (2003). Prevalence of the K76T mutation in the pfcrt gene of Plasmodium falciparum among chloroquine responders in India. Acta Tropica 87, 287-293.
34. Walliker, D. (2005). The hitchhiker's guide to malaria parasite genes. Trends in Parasitology 21, 489-493.
35. Warhurst, D. C. (2003). Polymorphism in the Plasmodium falciparum chloroquine resistance transporter protein links verapamil enhancement of chloroquine sensitivity with the clinical efficacy of amodiaquine. Malaria Journal 19, 31.
36. Wellems, T. E., Panton, L. J., Gluzman, I. Y., Rosário, V. E., Gwadz, R. W., Walker-Jonah, A. and Krogstad, D. J. (1990). Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross. Nature, London 345, 253-255.
37. Wellems, T. E. and Plowe, C. V. (2001). Chloroquine-resistant malaria. Journal of Infectious Diseases 184, 770-776.
38. Wernsdorfer, W. H. and Noedl, H. (2003). Molecular markers for drug resistance in malaria: use in treatment, diagnosis and epidemiology. Current Opinion in Infectious Diseases 16, 553-558.
39. Wootton, J. C., Feng, X., Ferdig, M. T., Cooper, R. A., Mu, J., Baruch, D. I., Magill, A. J. and Su, X. Z. (2002). Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature, London 418, 320-323.
40. Zalis, M. G., Pang, L., Silveira, M. S., Milhous, W. K. and Wirth, D. F. (1998). Characterization of Plasmodium falciparum isolated from the Amazon region of Brazil: evidence for quinine resistance. American Journal of Tropical Medicine and Hygiene 58, 630-637.